Lifebit

Lifebit, founded in 2017, builds a federated, AI-powered trusted research environment for the secure analysis of genomic and clinical data. Its approach is to bring analysis to where the data resides rather than moving the data itself, allowing institutions to collaborate on biomedical research while retaining data sovereignty and meeting regulatory requirements such as GDPR and HIPAA.

The company's core product, the Federated Trusted Research Environment, is described as the world's first federated trusted research environment. It is designed for pharmaceutical companies, national health systems, governments and research institutions working across genomics and clinical data. The platform serves clients spanning more than 275 million patient records, and the company has raised $60M in Series B funding.

Lifebit's technical work covers federated learning, AI-powered data intelligence, genomics, bioinformatics, data privacy and security, cloud computing and health data analytics. It operates globally across healthcare, life sciences, pharmaceuticals, biobanks, hospitals and government health systems, with applications in precision medicine, drug discovery and clinical trials.

The company describes its focus in terms of broadening access to biomedical data, with an emphasis on patient privacy, data sovereignty, security and regulatory compliance, and on enabling collaboration between institutions.